Page last updated: 2024-10-21

zopolrestat and Fibrosis

zopolrestat has been researched along with Fibrosis in 1 studies

zopolrestat: structure given in first source

Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.

Research Excerpts

ExcerptRelevanceReference
"The combination of peritoneal exposure to dialysis fluids and administration of zopolrestat, a newly developed inhibitor of aldose reductase activity, resulted in less fibrosis and fewer peritoneal vessels than exposure to dialysis fluids only, in a long-term exposure model in the rat."3.73Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution. ( Aberra, M; Aten, J; Deira, G; Dragt, CA; Krediet, RT; van Westrhenen, R, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Westrhenen, R1
Aten, J1
Aberra, M1
Dragt, CA1
Deira, G1
Krediet, RT1

Other Studies

1 other study available for zopolrestat and Fibrosis

ArticleYear
Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2005, Volume: 25 Suppl 3

    Topics: Aldehyde Reductase; Animals; Benzothiazoles; Dialysis Solutions; Enzyme Inhibitors; Fibrosis; Glucos

2005